Essential Reading
Frontier Institute released an analysis outlining concerns for potential misuses of Artificial Intelligence in healthcare...
Georgia Public Policy Foundation released a study exposing how CON laws do not help underserved populations...
In the News
In the Washington Examiner, the Pacific Research Institute argues Medicaid work requirements should have been in the debt limit deal...
In Forbes, the Pacific Research Institute’s Sally Pipes outlines how lawmakers can slash Medicare spending without cutting benefits...
Essential Reading
The Inflation Reduction Act is threatening research and development for medications urgently needed to meet complex health challenges American seniors are enduring.
Since he was elected to Congress in 1991, Senator Sanders has made numerous stemwinding speeches about drug prices, many during the time when per capita drug costs were rising, from under $200 annually in 1980 to about $1000 by 2004. Sanders’ speeches resonated with many back then, as few had ever paid $200 per month for a medicine. This drug cost trend, of course, was not simply due to rising prices but also to many new drugs entering the U.S. pharmacopeia. But this all changed in the mid-2000s.
